期刊
CANCER LETTERS
卷 247, 期 1, 页码 130-136出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2006.03.029
关键词
CA125; mesothelin; high-throughput screening; cell adhesion model system; ovarian cancer
类别
资金
- NCI NIH HHS [P50 CA83636, P50 CA083636, P50 CA083636-06] Funding Source: Medline
- NIGMS NIH HHS [R37 GM017709, R01 GM017709-31, R01 GM017709, GM 17709] Funding Source: Medline
Preventing peritoneal implantation of ovarian carcinoma cells could prolong patient remission and survival. CA125 is expressed on most ovarian cancer cells and was reported to be a ligand of mesothelin, a peritoneal protein. We developed a cell adhesion assay with CA125-expresser ovarian cancer cells and human mesothelin-transfected cells and we confirmed that CA125 and mesothelin mediate cell attachment. We also showed that this assay supplies a high-throughput screening system for reagents able to block CA125/mesothelin-dependent cell attachment with a sensitive quantitative readout. We finally demonstrated that a mesothelin chimeric protein and anti-CA125 antibodies block CA125/mesothelin-dependent cell attachment. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据